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Natural killer cell NKG2D and granzyme B are critical
for allergic pulmonary inflammationq
Nazanin Farhadi, MSc,a Laura Lambert, BA,a Chiara Triulzi, PhD,b Peter J. M. Openshaw, FMedSci,a Nadia Guerra, PhD,b
and Fiona J. Culley, PhDa London, United KingdomBackground: The diverse roles of innate immune cells in the
pathogenesis of asthma remain to be fully defined. Natural killer
(NK) cells are innate lymphocytes that can regulate adaptive
immune responses. NK cells are activated in asthma; however,
their role in allergic airway inflammation is not fully understood.
Objective: We investigated the importance of NK cells in house
dust mite (HDM)-triggered allergic pulmonary inflammation.
Specifically, we aimed to determine the role of the major NK-
cell activating receptor NKG2D and NK-cell effector functions
mediated by granzyme B.
Methods: Allergic airway inflammation was induced in the
airways of mice by repeated intranasal HDM extract
administration and responses in wild-type and NKG2D-deficient
mice were compared. Adoptive transfer studies were used to
identify the cells and mechanisms involved.
Results: Mice that lacked NKG2D were resistant to the
induction of allergic inflammation and showed little pulmonary
eosinophilia, few airway TH2 cells, and no rise in serum IgE
after multiple HDM-allergen exposures. However, NKG2D was
not required for pulmonary inflammation after a single
inoculation of allergen. NKG2D-deficient mice showed no
alteration in responses to respiratory virus infection. Transfer of
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cells expressed granzyme B.
Conclusions: These studies established a pivotal role for NK-cell
NKG2D and granzyme B in the pathogenesis of HDM-induced
allergic lung disease, and identified novel therapeutic targets for
the prevention and treatment of asthma. (J Allergy Clin
Immunol 2014;133:827-35.)
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Asthma is a chronic disease of increasing prevalence that
affects 300 million people worldwide.1,2 Current therapies are of
limited efficacy, so there is a pressing need for further understand-
ing of the immune pathways that drive allergic lung disease.
There is a growing interest in the role of innate cells in the
initiation of allergic airway inflammation. Allergens, including
those of the house dust mite (HDM), Dermatophagoides ptero-
nyssinus, the most common trigger of allergic asthma worldwide,
can trigger pattern recognition receptors on antigen-presenting
cells and on structural cells, such as respiratory epithelial cells,3-5
which leads to the activation of innate immune cells, including
type-2 innate lymphocytes, gd T cells, NKT cells, and dendritic
cells, which promote TH2 immune responses.
6-10
Natural killer (NK) cells comprise approximately 10% of lung
lymphocytes in homeostasis inman andmouse.11 They are known
to kill transformed and infected cells, and they act as a potent
source of IFN-g, thus promoting TH1 responses, but they also
can produce pro- and anti-inflammatory cytokines, including
IL-5, IL-10, and IL-13.12-14 In addition, NK cells can regulate
adaptive responses by direct killing of activated leukocytes,
including dendritic cells, macrophages, and T cells.15-18 NK cells
express an array of different activating and inhibitory receptors
that exhibit nonredundancy in vivo, for example, NKp46
is required for protection against influenza virus infection.19
Therefore, NK-cell receptors are attractive potential targets for
specific therapies, and, thus, there is a need to better define the
roles of individual NK-cell receptors in diverse diseases.
NKG2D is an activating receptor expressed on all mature NK
cells, NKT cells, and subsets of gd and ab T cells.20,21 The
NKG2D receptor mediates the ‘‘stress surveillance’’ function of
NK cells and recognizes ligands from the H60, MULT-1, and
the Rae-1 families in mice, and MHC class I chain-related
molecules (MICA or MICB) and UL16-binding proteins in
man, which are induced in response to DNA damage and on
transformed cells.22,23 NKG2D has been implicated in tumor
clearance, graft rejection, atherosclerosis, autoimmunity, and
infection.22,24-29 In murine models, activation of skin intraepithe-
lial lymphocytes via NKG2D can promote systemic atopy.30 In827
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NKG2D, which correlates with blood eosinophilia.31 Further-
more, NKG2D ligands MICA and ULBP-2 are elevated in the
serum of children with respiratory symptoms of HDM allergy.32
To explore the role of NKG2D expression by NK cells in the
induction and control of atopic lung disease, we studied
the inflammatory response after challenge with HDM extract. NK
cells were recruited to the lungs and airways in this model, and the
NKG2D ligand MULT-1 was selectively upregulated in the lung.
Allergic inflammation was severely attenuated in mice deficient in
NKG2D but was restored in NKG2D-deficient mice by adoptive
transfer of wild-type but not granzyme B deficient NK cells. These
data provide evidence that NK cells are critical for enhancing lung
inflammation in response to HDM allergen, and they do this via
both NKG2D and granzyme B production.
METHODS
Mice
FemaleBALB/c, C57BL/6, and granzymeBdeficient (gzmb2/2)micewere
purchased from Jackson Labs (Charles River Ltd, Margate, United Kingdom)
and were used at 6-8 weeks old. NKG2D deficient (klrk12/2) mice, which
were on the C57BL/6 background, were genotyped as described.24 The
animals were housed at the Imperial College London animal facility with
food and water ad libitum. UK Home Office guidelines for animal welfare
based on the Animals (Scientific Procedures) Act 1986 were strictly observed.
For experiments that involved NKG2D deficient mice, wild-type control
animals were age- and sex-matched littermates (klrk11/1).
Allergen challenge and tissue processing
To induce allergic airway inflammation, the mice were challenged by
intranasal instillation of 25 mL of a 1 mg/mL solution of whole HDM extract
(Greer Laboratories, Inc, Lenoir, NC) in PBS under isoflurane inhalational
anesthesia, 3 times a week for 3 weeks.33,34 In other experiments, the mice
received a single dose of 70 mg of HDM extract. Control mice received
PBS. Responses were analyzed 24 hours after the last challenge. For respira-
tory syncytial virus (RSV) infection, RSV strain A2 (ATCC, Manassas, Va)
was grown in Hep-2 cells. The mice received 106 pfu or control Hep-2 cell
lysate, intranasally in 50 mL. The mice were weighed daily, and responses
were analyzed 4 days after challenge.
The mice were bled under terminal anesthesia by cardiac puncture to
collect blood for serum. Bronchoalveolar lavage (BAL) was performed by
flushing the lungs 3 times with 1 mL 5 mM EDTA, PBS via a tracheal
cannula. Lung vasculature was perfused in situ with PBS via the right atrium.
Mediastinal lymph nodes were removed, and single cell suspensions were
obtained by passing the nodes through a 100-mm mesh. For histologic
analysis, one lobe of lung was inflated with PBS and fixed in 10% normal
buffered formalin. Specimens were paraffin embedded, transverse sectioned
(4 mm) onto glass slides, and stained with hematoxylin and eosin. Images
were recorded by using a310 objective lens (Zeiss Axioscope.A1; Carl Zeiss
Ltd, Welwyn Garden City, United Kingdom). For PCR, lung tissue was snap
frozen in liquid nitrogen. For analysis of the lung cellular response, lung
tissue was digested with collagenase XI (Sigma Aldrich Company Ltd,Gillingham, United Kingdom), and single-cell suspensions were obtained
by using a gentle MACS dissociator (Milltenyi Biotec Ltd, Woking, United
Kingdom). After isolation of leukocytes from each tissue and lysis of
erythrocytes in ACK buffer (150 mM ammonium chloride, 10 mM potassium
bicarbonate, 0.1 mM EDTA), total cell counts were obtained on a FACSCanto
flow cytometer (BD Biosciences, Becton Dickinson UK Limited, Oxford,
United Kingdom) by using CountBright counting beads (Life Technologies
Ltd, Paisley, United Kingdom). For differential cell counts, BAL leukocytes
were applied to glass slides by centrifugation (Shandon Cytospin II; Thermo
Fisher Scientific, Loughborough, United Kingdom), fixed, and stained with
Quick-Diff (Reagena; International Oy Ltd, Toivala, Finland).Flow cytometry
The cells were stained with combinations of the following antibodies.
Alexafluor 700 or allophycocyanin (APC)-H7 conjugated mAb to CD4
(GK1.5), Pacific Blue conjugated mAb to CD8 (35-6.7), Alexafluor 700 or
PerCP-Cy5.5 conjugated mAb to NKp46 (29A1.4), PE-Cy7 conjugated mAb
to IFN-g (XMG1.2) and FITC conjugated mAb to gd-TCR (GL3) were
purchased from BD Biosciences. APC-efluor780 conjugated mAb to CD3
(17A2), PE conjugated mAb to IL-13 (eBio13A), PE conjugated mAb to
NKG2D (CX5), PE-Cy7 mAb to CD69 (H1.2F3), APC-conjugated mAb to
IL-4 (11B11), and APC conjugated mAb to NK1.1 (PK136) were purchased
from eBioscience (Hatfield, United Kingdom). APC conjugated mAb to
Granzyme B (GB12) was purchased from Life Technologies.
For intracellular cytokine staining, cells were first stimulated with
100 ng/mL PMA, 1 mg/mL ionomycin (Sigma Aldrich) in the presence of
GolgiStop (BD Biosciences) for 4 hours. The cells were stained with aqua
live/dead stain (Life Technologies), followed by staining for surface antigens,
fixation, then permeabilization for intracellular staining. Flow cytometric
acquisition was performed on a FACS Fortessa (BD Biosciences) by using
Diva software and a minimum of 50,000 live, single-cell events were
collected. Analysis was carried out by using FlowJo software (Tree Star Inc,
Ashland, Ore). Dead cells were gated out, and doublets were excluded by
means of forward scatter-width (FSC-W) versus FSC-area (FSC-A).Sorting and adoptive transfer
Splenic NK cells (CD32NKp461 lymphocytes) or CD31 lymphocytes
from wild type, klrk12/2 and gzmb2/2 mice were sorted on a FACSAria III
(Becton Dickenson, UK Ltd, Oxford, United Kingdom). Dead cells and
doublets were excluded, and purity of sorted cells was typically 98%.
A total of 0.5 3 106 cells were transferred intravenously per mouse 24 hours
before the first HDM challenge.PCR analysis
Lung tissue was homogenized by using a TissueLyser (Qiagen,
Manchester, United Kingdom), and total RNA was isolated by using an
RNeasy mini kit (Qiagen). Reverse transcription was carried out by using the
high-capacity cDNA kit (Applied Biosystems, Life Technologies). RT-PCR
was performed on an Applied Biosystems 7500 real-time PCR system by
using Taqman universal PCR master mix (Applied Biosystems) and
FAM-TAM-labeled probes to measure expression of murine MULT-1
(ulbp1), Rae-1 family members (rae1), KC (cxcl1), LIX (cxcl5), and CCL2
(ccl2). Fold change in expression of mRNA was quantified by the 2DDCt
method by using GAPDH as internal control (Applied Biosystems). PCR
for the RSV L gene was performed, as described, normalized to 18s gene
expression, and copy number was determined by using a plasmid that contains
the RSV L gene as standard.35Protein measurements
Total serum IgE concentrationwasmeasured by using a total IgEELISA kit
(BD Biosciences). Antigen-specific serum IgE was measured as described.36
The BAL total protein concentration was assessed by Bradford assay (Sigma
Aldrich).
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A group size of 5-6 mice was used. Unless otherwise indicated, data are
expressed as mean (6SEM). Statistically significant differences between
groups were determined by using a nonparametric Mann-Whitney U test.
A P value of <.05 was accepted as significant. Results are indicated on figures
as *P < .05; **P < .01, ***P < .001 or ns (not significant). PCR data were
considered as normally distributed, and 1-way ANOVA with a Bonferroni
post hoc test was used to assess significance. Graph generation and
statistical analysis was performed by using GraphPad Prism software (version
5.00; GraphPad Software Inc, La Jolla, Calif). Data are representative of
2-4 independent experiments.RESULTS
NKG2D regulates HDM-allergic lung inflammation
Allergic inflammation was induced in the airways of mice by
intranasal inoculation of HDM extract 3 times a week over
3 weeks. This induces a pronounced eosinophilia and the
recruitment of Th2 cells (CD41IL-41 and CD41IL-131 lympho-
cytes) to the airway.33,34 Although NK cells are present at low
numbers in the airways and lung tissue in homeostasis, we found
that they are greatly increased in number in allergic inflammation
and that their increase in numbers in the airways over the course
of induction of allergic inflammation paralleled development
allergic inflammation (Fig E1 [in this article’s Online Repository
at www.jacionline.org] and NKp461CD32 lymphocytes [Fig 1,
E]). Further characterization of the NKp461 airway lymphocytes
in allergic inflammation revealed that these cells were activated
(CD69 expression) and exhibited the NKG2D1 granzymeB1
phenotype of conventional, cytotoxic NK cells (Fig E2 in this
article’s Online Repository at www.jacionline.org).
To determine the role of NKG2D in allergic lung inflammation,
HDM allergen was administered to mice deficient in this
receptor (klrk12/2 mice). Remarkably, klrk12/2 mice exhibited
a profoundly impaired inflammatory response to allergen
challenge compared with klrk11/1 mice, with virtual abolition
of the peribronchiolar inflammatory infiltrate seen in klrk11/1
mice (Fig 1, A). Reflecting this reduced inflammation, the amount
of total protein exudate into the airway, as measured in the BAL,
did not increase in NKG2D-deficient mice (Fig 1, B) after
allergen challenge. Furthermore, cellular recruitment was greatly
attenuated in klrk12/2 mice, specifically, there was a reduction
in numbers of neutrophils, eosinophils, and lymphocytes in the
airways compared with wild-type mice (Fig 1, C and D).
Within the lymphocyte populations, the numbers of gdT cells,
NKp461CD32 lymphocytes, CD81, and CD41 T cells recruited
to the airways were lower in klrk12/2 mice (Fig 1, E).
Furthermore, the total numbers of IL-4 and IL-13 secreting
CD41 cells in the airways were severely reduced (Fig 1, F)
and within the recruited CD41 T cells, the proportions secreting
IL-4 and IL-13 were significantly lower in klrk12/2 compared
with klrk11/1 mice (11.4% 6 2.4% vs 5.4% 6 0.7% and
22.2% 6 3.1% vs 11.7% 6 0.8%; respectively, mean 6 SEM,
P < .05). The total number of IFN-g1 CD41 cells were reduced
in the airways of klrk12/2mice (Fig 1, F), but CD41 lymphocyte
IFN-g production increased as a proportion of CD41 cells (from
9%6 1.6% to 19%6 3%,mean6 SEM, P <.05). The proportion
of IFN-g secreting CD81 cells in klrk12/2 and klrk11/1micewas
comparable (data not shown). Total serum IgE and HDM-specific
IgE in klrk12/2 mice was not elevated above that of naive mice
(Fig 1, G). Importantly, changes in the inflammatory response
seen in the airways were consistently reflected in changes tocell populations in the lung tissues (data not shown). Therefore,
NKG2D deficiency leads to a profound impairment of
HDM-allergic airway inflammation, and these data support a
critical function for NKG2D in promoting this response.NKG2D does not alter inflammation and viral
clearance in respiratory viral infection
The klrk12/2 mice used in this study exhibit only minor
alteration in their NK cell receptor repertoire and respond
normally to MCMV infection.37 Nevertheless, the attenuated
inflammatory responses in NKG2D-deficient mice in response
to HDM could reflect an alteration in NK-cell responsiveness or
in immune responses in the lung. To address this, we infected
mice with RSVand examined the viral load and immune response
4 days later. In this model, NK cells are recruited to the lungs
within a few days of infection and promote the development of
adaptive type 1 immunity.38,39 We detected no differences in viral
load in klrk12/2mice, as measured by copies of viral L-gene at 4
days after infection, the peak of viral load in this model (see Fig
E3, A in this article’s Online Repository at www.jacionline.org).
Furthermore, there were no differences in responses to RSV
infection in terms of total inflammatory cell recruitment into
the airways (Fig E3, B) and the nature of the inflammatory
infiltrate (Fig E3, C). NK cell (NKp461CD32 lymphocyte)
numbers in the airways and their IFN-g production was unaltered
in klrk12/2 mice compared with klrk11/1 mice (Fig E3, D).
Development of the CD41 or CD81 lymphocyte response was
similarly unaltered (Fig E3,E andF). No IL-4 or IL-13 expressing
lymphocytes were detected, and the RSV-induced weight loss did
not differ between groups (data not shown). Analysis of these data
demonstrates that, unlike HDM allergen challenge, after a
respiratory viral infection, NKG2D-deficient mice are able to
mount a robust inflammatory response in the lung, recruit
NK cells, and control viral infection.NKG2D ligand MULT-1 is expressed in the lung in
HDM-allergic inflammation
To understand how NKG2D may be triggered after allergen
challenge, we measured NKG2D ligand expression in lung
tissue 24 hours after the final of 9 challenges with HDM extract.
MULT-1 (ulbp1) and rae1d and rae1ε are expressed in C57BL/6
mice, but H60 is not transcribed.40 Quantitative PCR demon-
strated that there was localized, increased expression of the
NKG2D ligand MULT-1 (ulbp1) but not Rae-1 family members,
in the lung tissue (Fig 2, A and B). Increased expression of
MULT-1 occurred equally well in klrk12/2 mice as klrk11/1.
Therefore, the cell-stress response is activated in the lung after
challenge with HDM allergen, but this is not NKG2D dependent.NKG2D does not regulate the early innate response
to HDM
Early innate responses are triggered after detection of HDM
allergen by resident lung cells, such as epithelial cells.5 Therefore,
to determine the influence of NKG2D on early responses to
allergen, we administered a single dose of HDM extract into the
airways and assessed the inflammatory response 24 hours later.
The klrk12/2 mice expressed chemokines KC (cxcl1), LIX
(cxcl5), and MCP1 (ccl2) (Fig 3, A-C) and developed a marked
FIG 1. Inflammation in HDM-allergic airway disease is NKG2D dependent. A, Lungs of wild type (WT) or
NKG2D-deficient (KO) mice challenged with PBS or HDM. B, BAL fluid protein concentration. C, Total
number of airway cells. D, differential counts. E, Total airway gdTCR1, NKp461, CD31CD81, and CD31CD41
lymphocytes. F, Total airway IL-4, IL-13, and IFN-g1 CD41 lymphocytes. G, Total concentration and HDM
specific serum IgE. Scale bar 5 100 mm. ns, Not significant. *P < .05 and **P < .01.
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FIG 2. NKG2D ligand MULT-1 expression is upregulated in the lung during
HDM-allergic inflammation. Mult-1 (ulbp1) (A) and rae-1 (B) gene family
expression in whole lung in wild-type (WT) and NKG2D-deficient mice
(KO) after 9 doses of HDM, as determined by RT-PCR. Expression is shown
as fold change relative to PBS-challenged mice, normalized to GAPDH.
ns, Not significant. *P < .05 and **P < .01.
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(Fig 3, D). An early, localized recruitment of NK cells
(NKp461CD32) occurred in the airways within 24 hours, which
was unaltered by the absence of NKG2D (Fig 3, E). Thus, early
expression of cytokine genes and inflammatory cell recruitment
are not dependent on the presence of NKG2D.HDM allergic airway inflammation is regulated by
NK-cell intrinsic NKG2D
To determine which cells express NKG2D in the airways in
allergic inflammation, lung lymphocytes subsets were assessed
by flow cytometry. Lung lymphocytes were first gated for
NKG2D expression, and the constituent subpopulations were
characterized. Themajority (approximately 80%) of lymphocytes
expressing NKG2D were NK cells (NKp461CD32) (Fig 4) but
expression also was present on CD41 and CD81 T lymphocytes,
and gdT cells and NKT cells. Thus, NK cells are the major
lung population expressing the NKG2D activating receptor.
To determine whether NK-cell or T-cell intrinsic NKG2D
expression was sufficient to promote allergic inflammation,
NKp461CD32 or CD31 splenocytes were isolated
from wild-type C57BL/6 mice and adoptively transferred into
klrk12/2 mice 24 hours before the first of 9 doses of HDM
(Fig 5, A). The presence of transferred cells in the lung was
confirmed 24 hours after the final HDM dose by enumerating
NKG2D1 cells in lung tissue, and these constituted approxi-
mately 10% of NKp461 and approximately 5% of CD31 cells
(data not shown).
Importantly, the transfer of wild-type NK cells was able to
restore allergic inflammation to klrk12/2 mice, which results in
pronounced pulmonary inflammation (Fig 5,B) and inflammatory
cell numbers in the airways were equal to that in HDM challenged
klrk11/1 mice (Fig 5, C). Wild-type NK cells were sufficient to
restore airway macrophage, neutrophil, eosinophil, and lympho-
cyte recruitment to equal numbers and in equal proportions to
that seen in klrk11/1 mice (Fig 5, C and D). Furthermore,
numbers of IL-41, IL-131, and IFN-g1CD41 cells also were
equivalent to those present in the lungs of klrk11/1 mice after
transfer of NK cells into klrk12/2mice (Fig 5, D). Finally, serum
total IgE and HDM-specific IgE were also restored to the level
observed in klrk11/1 mice when wild-type NK cells wereadoptively transferred into klrk12/2mice (Fig 5, E). Importantly,
transfer of klrk12/2 NK cells did not restore allergic
inflammation, which served as a control for any nonspecific
effects of isolation and transfer, and nor did transfer of CD31
splenocytes (which consisted of 56% CD41, 37% CD81, 3%
gdTCR1, and 4% NKT cells) (Fig 5, F), which indicated that
NK cell, but not T cell, intrinsic expression of NKG2D promotes
HDM-allergic airway inflammation.
Granzyme B has been found to be elevated in the lungs of
people with asthma after allergen challenge.41,42 To directly
address the importance of granzyme B in NK-cell mediated
allergic inflammation, NK cells from granzyme B deficient
mice (gzmb2/2) were adoptively transferred into NKG2D-
deficient mice to determine if the allergic phenotype would be
restored. Interestingly, granzyme B deficient NK cells, similar
to NKG2D-deficient NK cells, were unable to restore allergic
inflammation (Fig 5, B to E), which indicated that both NKG2D
expression and granzyme B production by NK cells are required
to promote airway inflammation, TH2 cell recruitment to the lung
and serum IgE.
DISCUSSION
In this study, we showed, for the first time, that NK cells
promote allergic pulmonary inflammation in response to
HDM allergen by mechanisms dependent on NK-cell intrinsic
expression of the major activating receptor NKG2D and
granzyme B. Mice that are deficient in NKG2D are resistant to
HDM-allergic lung disease, which exhibit lower cell infiltration
and reduced TH2 responses. NKG2D did not influence the innate
response seen 24 hours after a single inoculation of HDM and was
not required for immune responses to respiratory viral infection.
Interestingly, adoptive transfer experiments demonstrated that
both NKG2D and granzyme B expression by NK cells is required
for the allergic response. Transfer of CD31 lymphocytes did not
restore allergic inflammation to NKG2D deficient mice, which
suggests that NKG2D expression on T lymphocytes and NKT
cells is not sufficient to promote allergic inflammation in this
model. In summary, we describe specific, nonredundant functions
for NK cell intrinsic NKG2D and granzyme B in HDM-allergic
lung inflammation.
Previous work with murine models of allergic airway
inflammation suggested a role for NK cells, but, because of the
potential off-target effects of antibodies used for depletion, these
studies are inconclusive.43-49 In our studies, we used NKp46 to
isolate NK cells for adoptive transfer. In the spleen, this marker
is exclusively expressed on NK cells,50 thus allowing conclusive
demonstration that NK cells promote allergic lung inflammation
in our model. Strid et al30 demonstrated a role for NKG2D
expressed on intraepithelial lymphocytes in induction of allergy
via the skin, and, when taken together with our data, this may
suggest a general role for NKG2D in the promotion of allergy.
We asked whether NKG2D was important for the adaptive or
the innate response to HDM allergen. After a single challenge
with HDM extract, we see no differences in NKG2D-deficient
mice, which suggests that NKG2D is exerting its influence on
the adaptive phase of the allergic response. Previous studies
have shown that NK cells promote the adaptive TH1 response
through the production of IFN-g after migration to the lymph
nodes12 and can produce type-2 cytokines,51 which contribute
to inflammation in helminth infection.14 Our data demonstrate
that NK-cell granzyme B rather than cytokine production, is
FIG 3. Inflammatory responses after a single dose of HDMare unaltered in NKG2D-deficientmice.Wild-type
(WT) or klrk12/2mice (KO)mice received a single dose of HDM or PBS. cxcl1 (A), cxcl5 (B), and ccl2 (C) gene
expression in the lung 24 hours after challenge relative to PBS-challenged mice. D, Numbers of airway
neutrophils. E, NKp461 cell numbers in the airways. ns, Not significant. **P < .01 and ***P < .001.
FIG 4. NK cells are the major NKG2D1 lymphocyte population in the lung in allergic inflammation wild-type
C57/Bl6 mice received HDM to induce allergic airway inflammation. A single-cell suspension of lung tissue
was analyzed by flow cytometry for NKG2D expression. Cells were gated on single cells and live
lymphocytes, then for NKG2D1 cells. The proportion of NKG2D1 cells that are in each lymphocyte subset
is shown in representative plots.
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exclude the possibility that NK cells making type-2 cytokines
contribute to inflammation. The importance of granzyme B as
an effector molecule suggests that cytotoxic mechanisms may
play a role and NK cells could regulate allergic inflammation
by targeting activated T cells, dendritic cells, or respiratory
epithelial cells.18,52-57 Alternatively, granzyme B can regulate
inflammation by noncytotoxic mechanisms, for example, IL-1a,which has undergone proteolysis by granzyme B, can promote
allergic airway inflammation.58-60
Our demonstration of the importance of NK-cell activation
in the HDM model of allergic airway disease is supported
by studies in asthma, which suggests that our murine model
is relevant to clinical disease. NK activity is high in the
peripheral blood of people with asthma.61-63 Furthermore, in
severe asthma, NK cells exhibit increased expression of
FIG 5. Restoration of airway inflammation by adoptive transfer of wild-type but not granzyme
B deficient NK cells. A, Protocol for adoptive transfer. B, Lung histology of klrk12/2 mice that
received NK cells from klrk12/2 mice (KO1KO); wild-type mice (KO1WT) or granzyme B deficient
mice (KO1GZMB2/2). C, Total airway cells and differential counts. D, Airway lymphocyte numbers
and cytokine-producing CD41 cells. E, Serum IgE measurements. F, Adoptive transfer of CD31
lymphocytes. Scale bar 5 100 mm. ns, Not significant. *P < .05 and **P < .01.
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molecules correlate with the percentage of peripheral blood
eosinophils.31 After allergen challenge in patients with allergic
asthma, granzyme B expressing NK cells and granzyme B
protein are elevated in the airways.41,42 Furthermore, the
NKG2D ligands MICA and ULBP-2, which can be cleaved
from the cell surface and detected in soluble forms in the
serum if produced in sufficient quantities, are elevated in
the serum of children with HDM allergy.32,64 Based upon
our findings, any factors that promote NK-cell activity would
be predicted to worsen inflammation in asthma. NK cells are
strongly activated by viral infection, and respiratory viral
infections are the single leading cause of asthma exacerba-
tions, which results in the major morbidity, mortality, and
health care costs associated with asthma.65 Thus, NK-cell
activation via NKG2D and their granzyme B production may
be important new therapeutic targets in asthma and allergic
disease.
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Key messages
d Natural killer cell intrinsic expression of the activating
receptor NKG2D is required for allergic pulmonary
inflammation in response to house dust mite extract.
d Natural killer cells promote allergic pulmonary inflam-
mation by production of granzyme B.
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FIG E1. NKp461 cell numbers in the airways over a time course of HDM-induced airway inflammation 9
doses of HDM were administered to BALB/c mice over 3 weeks to induce allergic airway inflammation.
TH2 cell (A), eosinophil (B), andNKp46
1 (C) cell numbers in the airways after 1, 4, and 9 doses of allergen.
ns, Not significant. **P < .01.
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FIG E2. Phenotypic analysis of airway NKp461 cells in HDM-allergic inflammation. A, CD69 expression in
lung lymphocytes in PBS- and HDM-challenged C57/Bl6 mice, and the total number of lung NKp461CD691
lymphocytes. B, Granzyme B expression in lung lymphocytes in PBS- and HDM-challenged mice, and the
total number of lung NKp461granzyme B1 lymphocytes. C, Expression of NKG2D and granzyme B in
NKp461 cells in the lungs in HDM-allergic inflammation. **P < .01.
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FIG E3. Immune responses to respiratory viral infection are NKG2D independent. Wild-type (WT) or
NKG2D-deficient (KO) mice were infected with RSV. A, Lung viral load. B, Total airway cell number.
C, Differential counts. D, Airway NKp461 and NKp461IFN-g lymphocyte numbers. E, Airway CD41 and
CD41 IFNg1 lymphocyte numbers. F, CD81 and CD81IFNg1 lymphocyte numbers and granzyme B
expression in CD81 lymphocytes. ns, Not significant. *P < .05 and **P < .01.
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